• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Task Force Members, Dieter Horstkotte, Chairperson*(Germany), Ferenc Follath
(Switzerland), Erno Gutschik (Denmark), Maria Lengyel (Hungary), Ali Oto (Turkey), Alain …

Infective endocarditis (IE) is a rare but potentially life-threatening disease, sometimes with
longstanding sequels among surviving patients. The population at high risk of IE is …

JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis Toggle navigation
J-STAGE home Browse All titles All subject areas All publishers Search articles Search …

Abstract Aims The European Society of Cardiology (ESC) EURObservational Research
Programme (EORP) European Endocarditis (EURO-ENDO) registry aims to study the care …

Infective endocarditis (IE) is uncommon but important because it is difficult to manage and
universally fatal unless appropriately treated. The estimated incidence is 3–10 episodes …

3. The epidemiological profile of IE has changed over the last few years, with newer
predisposing factors–valve prostheses, degenerative valve sclerosis, intravenous drug …

The BSAC guidelines on treatment of infectious endocarditis (IE) were last published in
2004. The guidelines presented here have been updated and extended to reflect …

Despite improvements in medical and surgical therapies, infective endocarditis is associated
with poor prognosis and remains a therapeutic challenge. Many factors affect the outcome of …